Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.

Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T.

Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030.

PMID:
22018552
2.

Mass eradication of Helicobacter pylori: feasible and advisable?

Mazzoleni LE, Francesconi CF, Sander GB.

Lancet. 2011 Aug 6;378(9790):462-4. doi: 10.1016/S0140-6736(11)61099-4. No abstract available.

PMID:
21777975
3.

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC, Meza-Montenegro MM, Peña R, Peña EM, Salazar-Martínez E, Correa P, Martínez ME, Valdivieso M, Goodman GE, Crowley JJ, Baker LH.

Lancet. 2011 Aug 6;378(9790):507-14. doi: 10.1016/S0140-6736(11)60825-8.

4.

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

Liou JM, Lin JT, Chang CY, Chen MJ, Cheng TY, Lee YC, Chen CC, Sheng WH, Wang HP, Wu MS.

Gut. 2010 May;59(5):572-8. doi: 10.1136/gut.2009.198309.

PMID:
20427390
5.

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F.

Ann Intern Med. 2009 Jul 21;151(2):121-8. Erratum in: Ann Intern Med. 2009 Oct 6;151(7):516.

PMID:
19620164
6.

Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?

de Vries AC, Kuipers EJ, Rauws EA.

Am J Gastroenterol. 2009 Jun;104(6):1342-5. doi: 10.1038/ajg.2008.15.

PMID:
19491846
7.

The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease.

Lee YC, Yen AM, Tai JJ, Chang SH, Lin JT, Chiu HM, Wang HP, Wu MS, Chen TH.

Gut. 2009 Feb;58(2):174-81. doi: 10.1136/gut.2008.162305.

8.

Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.

Yeh JM, Kuntz KM, Ezzati M, Goldie SJ.

Int J Cancer. 2009 Jan 1;124(1):157-66. doi: 10.1002/ijc.23864.

9.

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M; Japan Gast Study Group..

Lancet. 2008 Aug 2;372(9636):392-7. doi: 10.1016/S0140-6736(08)61159-9.

PMID:
18675689
10.

Helicobacter pylori colonization is inversely associated with childhood asthma.

Chen Y, Blaser MJ.

J Infect Dis. 2008 Aug 15;198(4):553-60. doi: 10.1086/590158.

12.

Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.

Lee YC, Lin JT, Wu HM, Liu TY, Yen MF, Chiu HM, Wang HP, Wu MS, Hsiu-Hsi Chen T.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):875-85.

13.

Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer.

Liu CY, Wu CY, Lin JT, Lee YC, Yen AM, Chen TH.

J Med Screen. 2006;13 Suppl 1:S2-5.

PMID:
17227633
14.

Inflammation, atrophy, and gastric cancer.

Fox JG, Wang TC.

J Clin Invest. 2007 Jan;117(1):60-9. Review.

15.

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ.

Gut. 2007 Jun;56(6):772-81.

16.

A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures.

Lee YC, Wu HM, Chen TH, Liu TY, Chiu HM, Chang CC, Wang HP, Wu MS, Chiang H, Wu MC, Lin JT.

Helicobacter. 2006 Oct;11(5):418-24.

PMID:
16961802
17.

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.

You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, Hu Y, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF Jr, Xu GW, Gail MH.

J Natl Cancer Inst. 2006 Jul 19;98(14):974-83.

18.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

19.

Long term follow up of patients treated for Helicobacter pylori infection.

Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P.

Gut. 2005 Nov;54(11):1536-40.

20.

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.

Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, Lau JY, Sung JJ.

Gut. 2004 Sep;53(9):1244-9.

Items per page

Supplemental Content

Support Center